Fact sheet: UBS (L)E-HlthCre$

Fund information

Fund name
UBS (Lux) Equity - Health Care (USD) P Acc
Fund company manager
UBS AG
Fund type
SIB
Fund manager(s)
Scott Wilkin
since 31/08/2016
Matthew Konosky
since 31/08/2016
Fund objective
Actively managed equity portfolio investing worldwide in companies from the healthcare sector. Efficient means of exploiting the potential of companies operating in the healthcare sector. Specialised sector analysts seek out the most attractive stocks in the healthcare sector worldwide. Investment decisions are based on a disciplined investment philosophy and fundamental research.
Benchmark
MSCI World Health Care Index
Investment style
None
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

14.51 %

1 Year rank in sector

13/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 187.5 m

FE Risk score

145

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    71.83%
  • France
    6.42%
  • Japan
    5.78%
  • Denmark
    4.82%
  • UK
    3.68%
  • Pharmaceuticals
    61.04%
  • Biotechnology/Medical
    16.46%
  • Health Care
    12.7%
  • Financials
    6.51%
  • Engineering & Machinery
    2.17%
  • US Equities
    71.83%
  • French Equities
    6.42%
  • Japanese Equities
    5.78%
  • Danish Equities
    4.82%
  • UK Equities
    3.68%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund0.61 %8.61 %14.51 %28.09 %89.36 %
Sector1.18 %8.1 %14.79 %27.68 %100.39 %
Rank within sector22 / 3116 / 3113 / 3014 / 2815 / 24
Quartile th3 rd3 rd2 nd2 nd3 rd

Calendar performance

YTD-20172016201520142013
Fund17.04 %-7.8 %9.21 %20.53 %34.91 %
Sector17.13 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector15 / 3010 / 3013 / 2822 / 2515 / 24
Quartile th2 nd2 nd2 nd4 th3 rd

Risk statistics

Alpha1.31
Beta0.8
Sharpe0.25
Volatility13.29
Tracking error6.1
Information ratio0
R-Squared0.85

Price movement

52 week high266.01
52 week low214.35
Current bid price0
Current offer price0
Current mid price261.87

Holdings by region

  • 71.83% USA
  • 6.42% France
  • 5.78% Japan
  • 4.82% Denmark
  • 3.68% UK
  • 2.51% Germany
  • 1.99% Switzerland
  • 1.47% Others
  • 0.86% Ireland
  • 0.64% Hungary

Holdings by sector

  • 61.04% Pharmaceuticals
  • 16.46% Biotechnology/Medical
  • 12.7% Health Care
  • 6.51% Financials
  • 2.17% Engineering & Machinery
  • 0.59% Mutual Funds
  • 0.54% Chemicals

Holdings by asset type

  • 71.83% US Equities
  • 6.42% French Equities
  • 5.78% Japanese Equities
  • 4.82% Danish Equities
  • 3.68% UK Equities
  • 2.51% German Equities
  • 1.99% Swiss Equities
  • 1.47% International Equities
  • 0.86% Irish Equities
  • 0.64% Hungarian Equities

Individual holdings

  • 6.41% SANOFI
  • 6.07% UNITEDHEALTH GROUP INC
  • 5.26% ABBOTT LABORATORIES
  • 4.81% NOVO NORDISK A/S
  • 4.76% CELGENE CORP
  • 4.67% MERCK & CO INC(NEW)
  • 3.99% LILLY (ELI) & CO
  • 3.85% JOHNSON & JOHNSON
  • 3.68% CIGNA CORP
  • 3.67% SHIRE PLC